vimetso 50 mg + 850 mg tabletki powlekane
krka, d.d., novo mesto - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg
vildagliptin + metformin hydrochloride +pharma 50 mg + 850 mg tabletki powlekane
+pharma arzneimittel gmbh - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg
vildagliptin + metformin hydrochloride +pharma 50 mg + 1000 mg tabletki powlekane
+pharma arzneimittel gmbh - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg
agnis 50 mg tabletki
belupo lijekovi i kozmetika d.d. - vildagliptinum - tabletki - 50 mg
alikval 50 mg tabletki
egis pharmaceuticals plc - vildagliptinum - tabletki - 50 mg
gluadda 50 mg tabletki
merck sp. z o.o. - vildagliptinum - tabletki - 50 mg
gluamet 50 mg + 1000 mg tabletki powlekane
merck sp. z o.o. - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg
gluamet 50 mg/tabl. + 850 mg/tabl. tabletki powlekane
merck sp. z o.o. - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg/tabl. + 850 mg/tabl.
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, type 2 - leki stosowane w cukrzycy - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 dla dostępnych danych o różnych kombinacjach).
pernuvi combi 50 mg + 850 mg tabletki powlekane
teva b.v. - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg